Vildagliptin

Sort by

Octahydro-5H,10H-dipyrrolo[1,2-a:1′,2′...

  • CAT Number DCTI-C-278
  • Cas Number 6/1/6708
  • Molecular Formula C10H14N2O2
  • Molecular Weight 194.23

VDN-Dihydroxy Impurity / 1-(((1r,3R,5S)-3,5-dihydr...

  • CAT Number DCTI-C-334
  • CAS Number NA
  • Molecular Formula C17H25N3O3
  • Molecular Weight 319.41

VDN-Pyrazine Impurity / 3-hydroxyhexahydropyrrolo[...

  • CAT Number DCTI-C-335
  • CAS Number 2797661-57-3
  • Molecular Formula C7H10N2O3
  • Molecular Weight 170.17

Vildagliptin Diketo Impurity

  • CAT Number DCTI-C-638
  • CAS Number 1789703-36-1
  • Molecular Formula C17H24N2O3
  • Molecular Weight 304.39

Vildagliptin Dimer Impurity

  • CAT Number DCTI-C-332
  • CAS Number 1036959-23-5
  • Molecular Formula C24H33N5O3
  • Molecular Weight 439.56

Vildagliptin Imino Impurity

  • CAT Number DCTI-C-331
  • CAS Number 1846606-31-2
  • Molecular Formula C17H23N3O2
  • Molecular Weight 301.39

Vildagliptin Impurity

  • CAT Number DCTI-C-486
  • CAS Number NA
  • Molecular Formula C17H25N3O3
  • Molecular Weight 319.41

Vildagliptin Mono Keto Impurity

  • CAT Number DCTI-C-280
  • CAS Number 1789703-37-2
  • Molecular Formula C17H25N3O2
  • Molecular Weight 303.41

Vildagliptin N-Oxide

  • CAT Number DCTI-C-405
  • CAS Number NA
  • Molecular Formula C17H25N3O3
  • Molecular Weight 319.41
LOAD MORE
You're viewed 18 of 22 products
References
FAQ's

Frequently Asked Questions

Controlling impurities in Vildagliptin ensures the drug’s quality, safety, and efficacy. They can affect Vildagliptin stability, pharmacological activity, and toxicity and interfere with the analytical methods used for its detection and quantification.

High-performance liquid chromatography-mass spectrometry helps accurately measure the levels of the impurities in Vildagliptin.

Regulatory agencies like the US FDA, EMA, and ICH establish acceptable limits for impurities in Vildagliptin. The limits may vary depending on the impurities ensuring that Vildagliptin meets stringent standards for its quality and suitability for patient use.

Impurities in Vildagliptin are controlled during the synthetic process by implementing good manufacturing practices (GMP) and using appropriate analytical methods for impurity identification and quantification.

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart